1)Abrams P, Cardozo L, Fall M Griffiths, et al:The standardisation of terminology of lowere urinary tract function:report from the Standardisation Sub-committiee of International Continence Society. Neurourol Uridyn 21:167-178, 2002
2)Michel MC, Oelke M, Goepel M, et al:Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients. Neurourol Urodyn 26:190, 2007
3)A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia. J Urol 150:1696, 1993
4)夜間頻尿診療ガイドライン作成委員会(編):夜間頻尿診療ガイドライン.ブラックウェルパブリッシング,東京,2009
5)五十嵐 隆,鈴木洋通,丸茂 健(監・編):腎・泌尿器疾患診療マニュアル—小児から成人まで.メジカルビュー,東京,2007
6)Miller, M:Nocturnal polyuria in older people:pathophysiology and clinical implications. J Am Geriatr Soc 48:1321, 2000
7)笠原正登,吉本明弘,鈴木隆夫:循環系の調節機構とその破綻がもたらす影響「腎循環」.救急医学28:153-157,2004
8)笠原正登,吉本明弘,上浦 望,他:病態と疾患からみたナトリウム利尿ペプチド.日本臨床(増刊)62:103-106,2004
9)DuBeau CE, Yalla SV and Resnick NM:Implications of the most bothersome prostatism symptom for clinical care and outcomes research. J Am Geriatr Soc 43:985, 1995
10)Kita H, Ohi M and Chin K:The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res 7:199-207, 1998
11)Bonanni E, Pasquali L, Manca ML, et al:Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients. Sleep Med 5:137-145, 2004
12)森 慶太,笠原正登:hANP(カルペリチ).循環器内科75:280-287,2014
13)Fujikawa K, Kasahara M, Matsui Y, et al:Human atrial natriuretic peptide is a useful criterion in treatment of nocturia. Scand J Urol Nephrol 35:310-313, 2001